title: Diagnosis of melanoma under concomitant natalizumab therapy.
authors.forename: Bettina M Prinz
authors.initials: BM
authors.lastname: Vavricka
authors.forename: Peter
authors.initials: P
authors.lastname: Baumberger
authors.forename: Stefan
authors.initials: S
authors.lastname: Russmann
authors.forename: Gerd A
authors.initials: GA
authors.lastname: Kullak-Ublick
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage / Q000009:adverse effects*; D008545:Melanoma / Q000175:diagnosis* / Q000209:etiology / Q000473:pathology; D009103:Multiple Sclerosis / Q000188:drug therapy*; D000069442:Natalizumab; D012307:Risk Factors; D012878:Skin Neoplasms / Q000175:diagnosis* / Q000209:etiology / Q000473:pathology
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007155:Immunologic Factors; D000069442:Natalizumab